Suppr超能文献

醌氧化还原酶与维生素K代谢

Quinone oxidoreductases and vitamin K metabolism.

作者信息

Gong Xing, Gutala Ramana, Jaiswal Anil K

机构信息

Department of Pharmacology, Baylor College of Medicine, One Baylor Plaza, Houston, Texas 77030, USA.

出版信息

Vitam Horm. 2008;78:85-101. doi: 10.1016/S0083-6729(07)00005-2.

Abstract

Vitamin K1, K2, and K3 are essential nutrients associated with blood clotting and bone metabolism. Quinone oxidoreductases [NAD(P)H:quinone oxidoreductase 1 (NQO1) and NRH:quinone oxidoreductase 2 (NQO2)] are among the selected enzymes that catalyze reduction of vitamin K to vitamin K hydroquinone. NQO1 catalyzes high affinity reduction of vitamin K3 but has only weak affinity for reduction of vitamin K1 and K2. Vitamin K hydroquinone serves as a cofactor for vitamin K gamma-carboxylase that catalyzes gamma-carboxylation of specific glutamic acid residues in Gla-factors/proteins leading to their activation and participation in blood clotting and bone metabolism. Concomitant with Gla modification, a reduced vitamin K molecule is converted to vitamin K epoxide, which is converted back to vitamin K by the enzyme vitamin K epoxide reductase to complete vitamin K cycle. Vitamin K is also redox cycled. One-electron reduction of vitamin K3 leads to the formation of semiquinone that in the presence of oxygen is oxidized back to vitamin K3. Oxygen is reduced to generate reactive oxygen species (ROS) that causes oxidative stress and cytotoxicity. Vitamin K is used as radiation sensitizer or in mixtures with other chemotherapeutic drugs to treat several types of cancer. ROS generated in redox cycling contributes to anticancer activity of vitamin K. NQO1 competes with enzymes that redox cycle vitamin K and catalyzes two-electron reduction of vitamin K3 to hydroquinone. This skips formation of semiquinone and ROS. Therefore, NQO1 metabolically detoxifies vitamin K3 and protects cells against oxidative stress and other adverse effects. On the contrary, NQO2 catalyzes metabolic activation of vitamin K3 leading to cytotoxicity. The role of NQO1 and NQO2 in metabolic detoxification and/or activation of vitamin K1 and K2 remains to be determined. Future studies are also required to identify the enzymes that catalyze high affinity reduction of vitamin K1 and K2 to hydroquinone for use in gamma-carboxylation reactions.

摘要

维生素K1、K2和K3是与血液凝固和骨骼代谢相关的必需营养素。醌氧化还原酶[烟酰胺腺嘌呤二核苷酸(磷酸):醌氧化还原酶1(NQO1)和还原型烟酰胺腺嘌呤二核苷酸:醌氧化还原酶2(NQO2)]是催化维生素K还原为氢醌型维生素K的特定酶。NQO1催化维生素K3的高亲和力还原,但对维生素K1和K2的还原亲和力较弱。氢醌型维生素K作为维生素Kγ-羧化酶的辅因子,催化Gla因子/蛋白中特定谷氨酸残基的γ-羧化,从而使其活化并参与血液凝固和骨骼代谢。伴随着Gla修饰,一个还原型维生素K分子转化为维生素K环氧化物,该环氧化物通过维生素K环氧化物还原酶转化回维生素K以完成维生素K循环。维生素K也进行氧化还原循环。维生素K3的单电子还原导致半醌的形成,在有氧气的情况下,半醌会被氧化回维生素K3。氧气被还原生成活性氧(ROS),从而导致氧化应激和细胞毒性。维生素K用作辐射增敏剂或与其他化疗药物混合使用以治疗多种类型的癌症。氧化还原循环中产生的ROS有助于维生素K的抗癌活性。NQO1与使维生素K进行氧化还原循环的酶竞争,并催化维生素K3双电子还原为氢醌。这跳过了半醌和ROS的形成。因此,NQO1在代谢上使维生素K3解毒,并保护细胞免受氧化应激和其他不良影响。相反,NQO2催化维生素K3的代谢活化,导致细胞毒性。NQO1和NQO2在维生素K1和K2的代谢解毒和/或活化中的作用仍有待确定。未来的研究还需要确定催化维生素K1和K2高亲和力还原为氢醌以用于γ-羧化反应的酶。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验